a public good project by the
Synthesis
Company
of California

© 2026

Victoria M. McLeod | doi.page

0 works0 citations0 h-index

Victoria M. McLeod

Peter MacCallum Cancer Centre(AU)Monash University(AU)

Publications by Year

Research Areas

Dendrimers and Hyperbranched Polymers, RNA Interference and Gene Delivery, Nanoparticle-Based Drug Delivery, Advanced biosensing and bioanalysis techniques, Inhalation and Respiratory Drug Delivery

Most-Cited Works

→ The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer(2021)211 cited
→ Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy(2014)187 cited
→ A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems(2011)169 cited
→ PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats(2009)144 cited
→ Pharmacokinetics and Tumor Disposition of PEGylated, Methotrexate Conjugated Poly-l-lysine Dendrimers(2009)139 cited
→ Association of Chemotherapeutic Drugs with Dendrimer Nanocarriers: An Assessment of the Merits of Covalent Conjugation Compared to Noncovalent Encapsulation(2012)137 cited

→ Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker(2011)133 cited

→ Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance(2011)74 cited

→ PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases(2013)74 cited

→ Doxorubicin-Conjugated PEGylated Dendrimers Show Similar Tumoricidal Activity but Lower Systemic Toxicity When Compared to PEGylated Liposome and Solution Formulations in Mouse and Rat Tumor Models(2012)69 cited